Fundraising Fox

Infinant Health

Sacramento, US · Delaware corporation · 6 known investors

infinanthealth.com ↗

Infinant Health develops a B. infantis probiotic pharmaceutical product (INF108, building on EVC001) aimed at preventing necrotizing enterocolitis (NEC) in preterm and very low birth weight infants in NICU care. The company commercializes gut microbiome technology derived from research at the University of California, Davis.

BiotechDigital HealthHealthtechWellness & Fitnessin /infinant-health@evivo_health

Founders & leadership

LS
Laura StoppelDirector
MJ
Michael JohnsonExecutive Officer, Director
ML
Mike LiangDirector
AB
Amanda Birdsey-BensonDirector
RW
Roger WyseDirector
PE
Patrick EnrightDirector
KK
Katharine KnobilDirector
JB
J. Bruce GermanCo-founder
DM
David MillsCo-founder
CL
Carlito LebrillaCo-founder
DB
Daniela BarileCo-founder
SF
Samara FreemanCo-founder & Director of Intellectual Property and Regulatory Affairs

Investors · 6

Acre Venture PartnersSanta Monica · $100K – $10M
Horizons VenturesHong Kong · $1M – $110M
iSelect FundSt. Louis · $250K – $2M
Longitude CapitalMenlo Park · $10M – $30M
Bill & Melinda Gates FoundationreportedSeattle
Spruce Capital PartnersreportedSouth San Franciscovia Roger Wyse · board

Reported raises · per SEC filings

Form D private placements
▶$39.2MraisedJun 2026 · 29 investors · Other Health Care
Rule 506(b)
Infinant Health has filed a notice of an exempt offering of securities to raise $118,230,513.00 in New Funding. - intelligence360intelligence360.news · Jul 2026
Officers, directors & promoters on the filing
  • Laura StoppelDirector
  • Michael JohnsonExecutive Officer, Director
  • Mike LiangDirector
  • Amanda Birdsey-BensonDirector
  • Roger WyseDirector
  • Patrick EnrightDirector
  • Katharine KnobilDirector
Offering amount
$118.2M
Amount sold
$39.2M
First sale
May 2026
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news